| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S13577-015-0123-5 |
| P698 | PubMed publication ID | 26250899 |
| P2093 | author name string | Shoichiro Mukai | |
| Toshiyuki Kamoto | |||
| Hiromasa Tsukino | |||
| Satoru Sugie | |||
| Koji Yamasaki | |||
| Toyoharu Kamibeppu | |||
| P2860 | cites work | The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression | Q27865253 |
| Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma | Q31034992 | ||
| Macrophage stimulating protein | Q33767118 | ||
| Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. | Q34379859 | ||
| Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks | Q34781947 | ||
| Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis | Q34854941 | ||
| Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor | Q35144580 | ||
| The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans | Q35758261 | ||
| Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma | Q35796063 | ||
| Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer | Q35836427 | ||
| The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma | Q36227180 | ||
| Serum hepatocyte growth factor and cancer mortality in an apparently healthy Japanese population | Q37234448 | ||
| Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo | Q37733681 | ||
| MSP-RON signalling in cancer: pathogenesis and therapeutic potential | Q38116308 | ||
| Developing biomarkers to predict benefit from HGF/MET pathway inhibitors | Q38150768 | ||
| Mechanisms of hepatocyte growth factor activation in cancer tissues | Q38255480 | ||
| Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010. | Q39839856 | ||
| Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases. | Q40020532 | ||
| The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression | Q40174257 | ||
| Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor | Q41034938 | ||
| Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species | Q41602145 | ||
| Hepatocyte growth factor activator (HGFA). | Q43093833 | ||
| Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein. | Q46003940 | ||
| Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostate cancer | Q46590851 | ||
| Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis. | Q53220940 | ||
| Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma. | Q55043279 | ||
| Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin- or cytokine-stimulated mouse macrophages | Q71624244 | ||
| Activation of macrophage-stimulating protein by human airway trypsin-like protease | Q83242699 | ||
| Expression of hepatocyte growth factor in prostate cancer may indicate a biochemical recurrence after radical prostatectomy | Q86431038 | ||
| P433 | issue | 1 | |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 22-29 | |
| P577 | publication date | 2015-08-07 | |
| P1433 | published in | Human Cell | Q26853933 |
| P1476 | title | Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression. | |
| P478 | volume | 29 |
| Q51466188 | Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis. |
| Q58555323 | Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair |
| Q52675438 | Role of the Nervous System in Tumor Angiogenesis. |
| Q91673432 | Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer |
| Q58777826 | Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation |
| Q38793227 | α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer |
Search more.